LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes.

Subramanian, Megha / McIninch, James / Zlatev, Ivan / Schlegel, Mark K / Kaittanis, Charalambos / Nguyen, Tuyen / Agarwal, Saket / Racie, Timothy / Alvarado, Martha Arbaiza / Wassarman, Kelly / Collins, Thomas S / Chickering, Tyler / Brown, Christopher R / Schmidt, Karyn / Castoreno, Adam B / Shulga-Morskaya, Svetlana / Stamenova, Elena / Buckowing, Kira / Berman, Daniel /
Barry, Joseph D / Bisbe, Anna / Maier, Martin A / Fitzgerald, Kevin / Jadhav, Vasant

Nature communications

2023  Volume 14, Issue 1, Page(s) 1970

Abstract: Adeno-associated virus (AAV)-based gene therapy could be facilitated by the development of molecular switches to control the magnitude and timing of expression of therapeutic transgenes. RNA interference (RNAi)-based approaches hold unique potential as a ...

Abstract Adeno-associated virus (AAV)-based gene therapy could be facilitated by the development of molecular switches to control the magnitude and timing of expression of therapeutic transgenes. RNA interference (RNAi)-based approaches hold unique potential as a clinically proven modality to pharmacologically regulate AAV gene dosage in a sequence-specific manner. We present a generalizable RNAi-based rheostat wherein hepatocyte-directed AAV transgene expression is silenced using the clinically validated modality of chemically modified small interfering RNA (siRNA) conjugates or vectorized co-expression of short hairpin RNA (shRNA). For transgene induction, we employ REVERSIR technology, a synthetic high-affinity oligonucleotide complementary to the siRNA or shRNA guide strand to reverse RNAi activity and rapidly recover transgene expression. For potential clinical development, we report potent and specific siRNA sequences that may allow selective regulation of transgenes while minimizing unintended off-target effects. Our results establish a conceptual framework for RNAi-based regulatory switches with potential for infrequent dosing in clinical settings to dynamically modulate expression of virally-delivered gene therapies.
MeSH term(s) RNA Interference ; Dependovirus/genetics ; Dependovirus/metabolism ; RNA, Small Interfering/metabolism ; Transgenes ; Genetic Therapy ; RNA, Double-Stranded ; Genetic Vectors/genetics
Chemical Substances RNA, Small Interfering ; RNA, Double-Stranded
Language English
Publishing date 2023-04-08
Publishing country England
Document type Journal Article
ZDB-ID 2553671-0
ISSN 2041-1723 ; 2041-1723
ISSN (online) 2041-1723
ISSN 2041-1723
DOI 10.1038/s41467-023-37774-5
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top